|
Other links at Biotechnology and Pharmaceuticals > Pharmaceuticals > Cancer > Research and Development |
| 1. |
Cytogen Corp.
|
|
|
Develops proprietary systems utilizing monoclonal antibodies for the targeted delivery of diagnostic and therapeutic substances in oncology. Includes information for investors, and healthcare professionals in the USA, from Princeton, New Jersey. (Nasdaq: CYTO)
|
| 2. |
Favrille, Inc.
|
|
|
Biopharmaceutical company focused on the research, development and commercialization of targeted immunotherapies for the treatment of cancer and other diseases of the immune system.
|
| 3. |
Onyx Pharmaceuticals, Inc.
|
|
|
Discovers and develops small molecule therapeutics based upon the genetics of human disease, with emphasis on cell growth inhibitors. Includes clinical pipeline, technology overview and investor relations at Richmond, California. (Nasdaq: ONXX)
|
| 4. |
Arqule, Inc.
|
|
|
Promotes their activated checkpoint therapy platform. Headquartered in Woburn, Massachusetts. (Nasdaq: ARQL)
|
| 5. |
Exelixis, Inc.
|
|
|
Genomics-based discovery company focused on development of drugs, crop protection, and plant biotechnology. Overview of research, investor relations and contacts in California and Portland, Oregon. (Nasdaq: EXEL)
|
|
|
Add to My Favorite
Refer it to Friend
Report Broken Link
